BioCentury | Nov 9, 2019
Company News

Management tracks: Teva, Ipsen, ADC, Assembly, Kaleido, Biodesix, CorMedix, Ideaya, Partner, Neurana, Odylia and T1D Exchange

...as CBO. He was CEO of Aeolus Pharmaceuticals Inc. (OTCQX:AOLS). Randall Kaye joined neuromuscular play Neurana Pharmaceuticals Inc....
...April. Jonathan Block, Associate Editor Ipsen S.A. ADC Therapeutics S.A. Relay Therapeutics Inc. Biodesix Inc. Odylia Therapeutics Inc. Kaleido Biosciences Inc. CorMedix Inc. T1D Exchange Neurana Pharmaceuticals Inc. Assembly...
BioCentury | Jul 17, 2018
Company News

Management tracks: Silence, Apeiron

...retired. The company named CFO and CBO Peter Llewellyn-Davies as the new CEO. Neuromuscular company Neurana Pharmaceuticals Inc....
BioCentury | May 11, 2018
Financial News

Neurana closes $60M series A

...participating were New Leaf Venture Partners, H.I.G. BioHealth Partners, Longitude Capital Management and MagnaSci Ventures. Neurana...
...formulations included levels of a sedative impurity that were higher than FDA allowed. Last year, Neurana...
...Josh Richardson joined Neurana's board. Neurana Pharmaceuticals Inc., San Diego, Calif. Mark Zipkin Agileo, Viveo, tolperisone (AV650) H.I.G. BioVentures Longitude Capital Management Neurana Pharmaceuticals Inc. New...
BioCentury | May 7, 2018
Financial News

Neurana closes $60M series A

...participating were New Leaf Venture Partners, H.I.G. BioHealth Partners, Longitude Capital Management and MagnaSci Ventures. Neurana...
...formulations included levels of a sedative impurity that were higher than FDA allowed. Last year, Neurana...
...Alex Zisson and Longitude's Josh Richardson joined Neurana's board. Mark Zipkin Agileo, Viveo, tolperisone (AV650) H.I.G. BioVentures Longitude Capital Management Neurana Pharmaceuticals Inc. New...
BioCentury | Oct 8, 2012
Company News

Katama Pharmaceuticals, Sanochemia deal

...countries. Katama declined to provide financial details, while Sanochemia could not be reached for comment. Katama Pharmaceuticals...
BioCentury | Oct 6, 2012
Company News

Newco Katama in deal for Sanochemia's tolperisone

...Sanochemia Pharmazeutika AG (Xetra:SAC) granted newco Katama Pharmaceuticals Inc. (San Diego, Calif.) exclusive rights in North America...
Items per page:
1 - 6 of 6
BioCentury | Nov 9, 2019
Company News

Management tracks: Teva, Ipsen, ADC, Assembly, Kaleido, Biodesix, CorMedix, Ideaya, Partner, Neurana, Odylia and T1D Exchange

...as CBO. He was CEO of Aeolus Pharmaceuticals Inc. (OTCQX:AOLS). Randall Kaye joined neuromuscular play Neurana Pharmaceuticals Inc....
...April. Jonathan Block, Associate Editor Ipsen S.A. ADC Therapeutics S.A. Relay Therapeutics Inc. Biodesix Inc. Odylia Therapeutics Inc. Kaleido Biosciences Inc. CorMedix Inc. T1D Exchange Neurana Pharmaceuticals Inc. Assembly...
BioCentury | Jul 17, 2018
Company News

Management tracks: Silence, Apeiron

...retired. The company named CFO and CBO Peter Llewellyn-Davies as the new CEO. Neuromuscular company Neurana Pharmaceuticals Inc....
BioCentury | May 11, 2018
Financial News

Neurana closes $60M series A

...participating were New Leaf Venture Partners, H.I.G. BioHealth Partners, Longitude Capital Management and MagnaSci Ventures. Neurana...
...formulations included levels of a sedative impurity that were higher than FDA allowed. Last year, Neurana...
...Josh Richardson joined Neurana's board. Neurana Pharmaceuticals Inc., San Diego, Calif. Mark Zipkin Agileo, Viveo, tolperisone (AV650) H.I.G. BioVentures Longitude Capital Management Neurana Pharmaceuticals Inc. New...
BioCentury | May 7, 2018
Financial News

Neurana closes $60M series A

...participating were New Leaf Venture Partners, H.I.G. BioHealth Partners, Longitude Capital Management and MagnaSci Ventures. Neurana...
...formulations included levels of a sedative impurity that were higher than FDA allowed. Last year, Neurana...
...Alex Zisson and Longitude's Josh Richardson joined Neurana's board. Mark Zipkin Agileo, Viveo, tolperisone (AV650) H.I.G. BioVentures Longitude Capital Management Neurana Pharmaceuticals Inc. New...
BioCentury | Oct 8, 2012
Company News

Katama Pharmaceuticals, Sanochemia deal

...countries. Katama declined to provide financial details, while Sanochemia could not be reached for comment. Katama Pharmaceuticals...
BioCentury | Oct 6, 2012
Company News

Newco Katama in deal for Sanochemia's tolperisone

...Sanochemia Pharmazeutika AG (Xetra:SAC) granted newco Katama Pharmaceuticals Inc. (San Diego, Calif.) exclusive rights in North America...
Items per page:
1 - 6 of 6